Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.
Open | $28.720 |
Close | $28.800 |
Volume / Avg. | 731.097K / 1.153M |
Day Range | 28.400 - 29.540 |
52 Wk Range | 15.115 - 45.580 |
Market Cap | $4.184B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 12.9% |
Days to Cover | 6.93 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunovant (NASDAQ: IMVT) through any online brokerage.
Other companies in Immunovant’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Immunovant (NASDAQ: IMVT) was reported by Oppenheimer on Thursday, March 28, 2024. The analyst firm set a price target for 50.00 expecting IMVT to rise to within 12 months (a possible 73.61% upside). 35 analyst firms have reported ratings in the last year.
The stock price for Immunovant (NASDAQ: IMVT) is $28.8 last updated Today at April 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Immunovant.
Immunovant’s Q4 earnings are confirmed for Monday, May 20, 2024.
There is no upcoming split for Immunovant.
Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.